miR-133b
rnaA circulating microRNA downregulated in coronary artery disease that regulates myogenic differentiation and inflammatory responses in ischemic tissue.
Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencemedium
RationalemiRNA downregulated early in CAD; muscle differentiation and inflammation regulator.
Also acts inVascular inflammation
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood or cell-free plasma
Collection tube
PAXgene/Tempus RNA tube · K2/K3-EDTA (lavender-top)
Method / principle
RT-qPCR (TaqMan) or small-RNA sequencing
Reagent / substrate
Target-specific primers/probe; reverse transcriptase (miRNA: stem-loop RT primer)
Platform
qPCR instrument / NGS
Turnaround · availability
Research / send-out · Research (few LDTs)
Literature evidence(1)
- Circulatory miR-133b and miR-21 as Novel Biomarkers in Early Prediction and Diagnosis of Coronary Artery Disease.Genes · 2020 · PMID 32033332 · doi